Due: July 11, 2025
The Joint Science and Technology Office (JSTO) Defense Threat Reduction Agency (DTRA) is charged with addressing the potential threat to the armed services posed by a wide range of bacterial, viral and toxin agents. This objective of this project is to identify current and developing technologies that can rapidly and accurately identify immunogenic regions of antigens in novel and emerging pathogens. This effort will fulfill JSTO Chem Bio Medical (CBM) vaccine program requirements by developing technologies to rapidly and accurately identify antigenic components in emerging pathogens that elicit significant and persistent protective immunity, and which can be incorporated into current vaccine platform(s).
Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium releases numerous solicitations throughout the year, so even if this opportunity may not end up being right for you, we strongly encourage you to join, so you are ready for the next opportunity.
Complete the form below and a program representative will reach out to you shortly to support you through the process.